Today Roche offers a broad portfolio of urinalysis solutions for different customer needs. Drawing on our 50 years of experience in urinalysis, starting with the launch of the first Combur-Test® strip, we have continuously improved strip technology for clinical and general practice. In response to customer needs for increased efficiency and safety, we have developed a range of analyzers with different degrees of automation and throughput capabilities. By combining the proven Combur-Test® strip technology4,5 with Roche automation, we offer customized urinalysis solutions for physician offices, hospital point-of-care and central laboratory settings.
Urinalysis has always been an important diagnostic tool in medicine.
Even today, urine is still a key health barometer for many diseases, mainly urinary tract infections, kidney disease and diabetes.1 The analysis of urine can reveal serious diseases that show no symptoms in their early stages but are treatable.2 These diseases can cause severe damage if they remain undetected.
Urine test strips are a crucial diagnostic tool which are easy to use and yielding quick, reliable information on pathological changes in the urine. Their diagnostic significance lies primarily in first-line diagnosis, screening during routine or preventive examinations, and treatment monitoring.3
References
Roche’s extensive urinalysis portfolio includes solutions for all workloads - from manual strip testing and POC devices for lower volume through to fully automated systems that can handle up to 240 samples per hour.
